​
​

Kiniksa Pharmaceuticals (KNSA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Kiniksa Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$270.26M

Latest Revenue (Q)

$112.21M

Main Segment (Y)

Product

Kiniksa Pharmaceuticals Revenue by Period

Kiniksa Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31-22.74%
2022-12-31-471.24%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--

Kiniksa Pharmaceuticals generated $270.26M in revenue during NA 2023, up 22.74% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Kiniksa Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30-3.30%
2024-06-30-36.03%
2024-03-31--4.24%
2023-12-31-24.38%
2023-09-30--6.19%
2023-06-30-47.84%
2023-03-31--21.88%
2022-12-31--37.58%
2022-09-30-267.55%
2022-06-30--16.21%
2022-03-31-71.72%
2021-12-31-54.98%
2021-09-30-57.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Kiniksa Pharmaceuticals generated $112.21M in revenue during Q3 2024, up 3.30% compared to the previous quarter, and up 157.00% compared to the same period a year ago.

Kiniksa Pharmaceuticals Revenue Breakdown

Kiniksa Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
Product--
Collaboration--

Kiniksa Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (86.28%), and Collaboration (13.72%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Collaboration---------
Product---------

Kiniksa Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (94.76%), and Collaboration (5.24%).

Kiniksa Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
KNSAKiniksa Pharmaceuticals--
CHRSCoherus BioSciences--
ACLXArcellx--
SPROSpero Therapeutics--
BOLTBolt Biotherapeutics--
KRONKronos Bio--
LYRALyra Therapeutics--
PHATPhathom Pharmaceuticals--
KRTXKaruna Therapeutics--
CGEMCullinan Oncology--
GPCRStructure Therapeutics--
GRCLGracell Bio--
NUVLNuvalent--
COGTCogent Biosciences--
GOSSGossamer Bio--
DAWNDay One Biopharmaceuticals--
CERECerevel Therapeutics--
REPLReplimune Group--
KURAKura Oncology--
NLTXNeurogene--
VTYXVentyx Biosciences--
LRMRLarimar Therapeutics--
NVCTNuvectis Pharma--

KNSA Revenue FAQ

What is Kiniksa Pharmaceuticals’s yearly revenue?

Kiniksa Pharmaceuticals's yearly revenue for 2023 was $270.26M, representing an increase of 22.74% compared to 2022. The company's yearly revenue for 2022 was $220.18M, representing an increase of 471.24% compared to 2021. KNSA's yearly revenue for 2021 was $38.54M, representing an increase of 100.00% compared to 2020.

What is Kiniksa Pharmaceuticals’s quarterly revenue?

Kiniksa Pharmaceuticals's quarterly revenue for Q3 2024 was $112.21M, a 3.30% increase from the previous quarter (Q2 2024), and a 67.37% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $108.63M, a 36.03% increase from the previous quarter (Q1 2024), and a 51.99% increase year-over-year (Q2 2023). KNSA's quarterly revenue for Q1 2024 was $79.86M, a -4.24% decrease from the previous quarter (Q4 2023), and a 65.18% increase year-over-year (Q1 2023).

What is Kiniksa Pharmaceuticals’s revenue growth rate?

Kiniksa Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 601.17%, and for the last 5 years (2019-2023) was 0%.

What are Kiniksa Pharmaceuticals’s revenue streams?

Kiniksa Pharmaceuticals's revenue streams in c 23 are Product, and Collaboration. Product generated $233.18M in revenue, accounting 86.28% of the company's total revenue, up 90.31% year-over-year. Collaboration generated $37.08M in revenue, accounting 13.72% of the company's total revenue, down -62.03% year-over-year.

What is Kiniksa Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Kiniksa Pharmaceuticals was Product. This segment made a revenue of $233.18M, representing 86.28% of the company's total revenue.